View Post

Israeli Company’s Vaccine Blocks 90% of Cancer Types

In In The News by Barbara Jacoby

By Arutz Sheva Staff From: Vaxil BioTherapeutics’s ImMucin trains immune system to fight cancer cells and prevent the disease’s return for early stages and remission. An Israeli biotech company is developing a vaccine for cancer that it says can help prevent the return of the lethal disease for 90% of the different types of cancer. Vaxil BioTherapeutics based in …

What’s attracting big pharma to pre-clinical deals?

In In The News by Barbara Jacoby

by Stephanie Baum Roche’s move to skip over Inovio’s (NYSE: INO) late stage drugs for cervical cancer and Hepatitis C and make a beeline for its preclinical DNA vaccines for prostate cancer and Hep B was initially a little puzzling. Investors have preferred to park their money further upstream when products are in the clinic and they’ve been derisked. Big …